Showing results (31-40 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|February 23, 2021
Optimising the trade-off between type I and II error rates in the Bayesian contextRosalind J Walley, Andrew P GrievePharmaceutical Statistics|February 17, 2017
Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practiceSheila M Bird, Rosemary A Bailey, Andrew P Grieve, et al.Pharmaceutical Statistics|September 10, 2019
Bayesian sample-size determination methods considering both worthwhileness and unpromisingness for exploratory two-arm randomized clinical trials with binary endpointsTomoyuki Kakizume, Fanghong Zhang, Yohei Kawasaki, et al.Pharmaceutical Statistics|April 5, 2008
Consequences of dichotomizationValerii Fedorov, Frank Mannino, Rongmei ZhangPharmaceutical Statistics|April 3, 2008
Exploring changes in treatment effects across design stages in adaptive trialsTim Friede, Robin HendersonPharmaceutical Statistics|May 16, 2008
Pharmacokinetic parameters estimation using adaptive Bayesian P-splines modelsAstrid Jullion, Philippe Lambert, Benoit Beck, et al.Pharmaceutical Statistics|April 1, 2025
Detection of Outlying Correlation Coefficients in Multicenter Clinical TrialsLieven Desmet, David Venet, Laura Trotta, et al.Pharmaceutical Statistics|March 27, 2025
Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary EndpointsXiaolong Luo, Lerong Li, Oleksandr Savenkov, et al.Pharmaceutical Statistics|March 29, 2025
The Choice Between Pearson's χ2 Test and Fisher's Exact Test for 2 × 2 TablesMarkus Neuhäuser, Graeme D RuxtonPharmaceutical Statistics|January 31, 2026
A Tobit Partly Linear Mixed and Mixture Cure Model for the Joint Analysis of Interval-Bounded Longitudinal Measurements and Survival Times With Cure ProportionZhanfeng Wang, Zerui Shen, Ruixing Ming, et al.Pageof 119